COL4A5

Chr XXLD

collagen type IV alpha 5 chain

Also known as: ASLN, ATS, ATS1, CA54

This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]

OMIMResearchGenerating clinical summary…
LOFmechanismXLDLOEUF 0.191 OMIM phenotype
Clinical SummaryCOL4A5
🧬
Gene-Disease Validity (ClinGen)
Alport syndrome · XLDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
💊
Clinical Trials
6 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.19LOEUF
pLI 1.000
Z-score 6.59
OE 0.10 (0.050.19)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
2.50Z-score
OE missense 0.72 (0.670.78)
474 obs / 653.9 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.10 (0.050.19)
00.351.4
Missense OE?0.72 (0.670.78)
00.61.4
Synonymous OE?1.03
01.21.6
LoF obs/exp: 6 / 61.9Missense obs/exp: 474 / 653.9Syn Z: -0.36
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveCOL4A5-related Alport syndromeLOFmonoallelic_X_heterozygous

This gene — mechanism propensity

DN
0.5477th %ile
GOF
0.3888th %ile
LOF
0.68top 10%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · LOEUF 0.19 · ClinGen HI: Sufficient evidence for dosage pathogenicity

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

COL4A5 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.